To further test the in vivo impact of TP73-AS1/miR-125a-3p/ACTN4 axis, we set up the subcutaneous xenograft tumor model with SPC-A1 treated with sh-TP73-AS1. This evidence concerns the gene ACTN4 and neoplasm.